Winners of WuXi PharmaTech Awards Inducted into Prestigious Academies
SHANGHAI, Dec. 23, 2013 /PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, congratulates five winners of the WuXi PharmaTech Life Science and Chemistry Awards on their inductions as new members of the highly prestigious Chinese Academy of Sciences (CAS) and Chinese Academy of Engineering (CAE).
CAS inducted four former WuXi award winners: Professors Jiahuai Han of Xiamen University (2009 award winner), Xiaoming Feng of Sichuan University (2010 award winner), George Fu Gao of the Institute of Microbiology at the CAS (2011 award winner), and Jie He of the Oncology Hospital at the Chinese Academy of Medical Sciences (2011 award winner). Professor Guangji Wang of China Pharmaceutical University (2008 award winner) was inducted into the CAE.
The WuXi PharmaTech Life Science and Chemistry Awards are the first nationwide scientific award in China established by a life science enterprise with the mission of fostering early innovation and encouraging the pursuit of excellence in the life sciences. Eight of the 95 scholars awarded between the awards' inception in 2007 and 2012 were later elected to the CAS or the CAE.
"We are proud to see the excellent work of five of our former award winners recognized by the CAS and the CAE," said Dr. Ge Li, Chairman and CEO of WuXi PharmaTech. "Their groundbreaking scientific research provides great insights into diseases and holds promise for better cures. The inductions are very well deserved."
About WuXi PharmaTech
As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. WuXi AppTec is the name for the operating subsidiaries of WuXi PharmaTech. For more information, please visit: http://www.wuxiapptec.com.
WuXi PharmaTech's Contacts:
Ronald Aldridge, Director of Investor Relations
+1 (201) 585-2048
Aaron Shi, Associate Director, Corporate Communications
SOURCE WuXi PharmaTech (Cayman) Inc.